Literature DB >> 18510523

von Willebrand disease update: diagnostic and treatment dilemmas.

P H B Bolton-Maggs1, D Lillicrap, J Goudemand, E Berntorp.   

Abstract

Although von Willebrand disease (VWD) is now well-described, many facets of diagnosis and management continue to be debated. The diagnosis of type 1 disease can be difficult but recent genetic analyses help to distinguish many factors which can influence von Willebrand factor (VWF) levels and bleeding phenotype. Type 2 disease (functional abnormalities) includes a particularly interesting group of disorders with faulty binding between VWF and FVIIIC (Normandy) where treatment methods need careful consideration. Type 3 VWD is the most severe form of VWD and a new international study is underway to examine the use of prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18510523     DOI: 10.1111/j.1365-2516.2008.01713.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  5 in total

1.  Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life.

Authors:  C Rae; W Furlong; J Horsman; E Pullenayegum; C Demers; J St-Louis; D Lillicrap; R Barr
Journal:  Haemophilia       Date:  2012-09-21       Impact factor: 4.287

2.  Intravascular recovery of VWF and FVIII following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice.

Authors:  Q Shi; E L Kuether; J A Schroeder; S A Fahs; R R Montgomery
Journal:  Haemophilia       Date:  2012-01-04       Impact factor: 4.287

3.  Perioperative Management of Type 2N Von Willebrand's Disease with Recombinant Factor VIII in a Patient Undergoing Knee-Replacement Surgery.

Authors:  Srivasavi Dukka; David John Allsup
Journal:  Case Rep Hematol       Date:  2013-02-03

4.  Cost-consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context.

Authors:  Piercarla Schinco; Dorina Cultrera; Federica Valeri; Alessandra Borchiellini; Michela Mantuano; Francesca Gorla; Alessia Savarese; Cristina Teruzzi
Journal:  Clinicoecon Outcomes Res       Date:  2014-12-17

Review 5.  Current therapy in children and adolescents with von Willebrand disease.

Authors:  I Buga-Corbu; C Arion
Journal:  J Med Life       Date:  2014-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.